Hillsdale Investment Management Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 241 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,440,242
-22.9%
96,548
-3.7%
0.41%
-23.1%
Q2 2023$5,758,955
-0.9%
100,208
-35.4%
0.53%
+6.2%
Q1 2023$5,813,926
+20.5%
155,038
-10.0%
0.50%
+22.1%
Q4 2022$4,826,109
-13.2%
172,238
-12.9%
0.41%
-18.7%
Q3 2022$5,557,000
-19.2%
197,7380.0%0.50%
-8.9%
Q2 2022$6,879,000
-18.2%
197,738
-15.6%
0.55%
+1.5%
Q1 2022$8,412,000
+1078.2%
234,338
+593.3%
0.54%
+664.8%
Q2 2019$714,000
+29.3%
33,800
+25.2%
0.07%
+42.0%
Q1 2019$552,000
+22.7%
27,000
+19.5%
0.05%
-5.7%
Q4 2018$450,00022,6000.05%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders